Home/DepYmed/Andreas Grill

AG

Andreas Grill

President & CEO

Therapeutic Areas

Rett Syndrome Oncology Wilson Disease Metabolic Diseases Neurodegenerative Diseases

DepYmed Pipeline

Drug	Indication	Phase
DPM-1003	Rett Syndrome	Phase 1
PTP1B Inhibitor	Oncology	Pre-clinical
Copper Chelator	Wilson Disease	Pre-clinical

Leadership Team at DepYmed

Peter Van Ess, PharmD, PhD

Senior Vice President of Early Development

Nicholas Tonks, PhD

Co-Founder & Research Advisor

View full DepYmed profile